 therapeut benefit calcium channel blocker cyclosporine-tr organ transplant recipi blood pressur control immunosuppress cyclosporin success rate form organ transplant use frequent occurr hypertens revers nephrotox iatrogen hypertens cyclosporin resembl low-renin salt-sensit form essenti hypertens salt restrict therapi renal salt acquisit diuret calcium channel blocker ccb ccb direct vasoconstrict effect cyclosporin effect vasoconstrictor endothelin thromboxan cyclosporin ccb immunosuppress cyclosporin minim nephrotox vitro combin verapamil cyclosporin addit inhibitori effect activ function human peripher blood mononuclear cell sever assay affer effer limb immunolog respons addit immunosuppress like drug effect circuitri addit inhibit product respons addit inhibit receptor express concentr verapamil cyclosporin combin verapamil cyclosporin mitogen-induc uptak inhibitori effect cyclosporin due inhibit lymphocyt activ direct inhibit calcium flux slow calcium channel drug addit effect transmembran flux calcium inact enantiom verapamil slow calcium channel ident immunosuppress capabl activ enantiom antiprolif effect verapamil slow-calcium-channel independ abil drug muscarin alpha opiat receptor lymphocyt lymphocyt potassium channel possibl verapamil necessari precursor molecul lymphocyt inact activ isomer form verapamil capabl thymidin uridin leucin incorpor lymphocyt necessari dna rna protein synthesi vitro observ clinic applic earli studi reject rate cyclosporine-tr transplant patient ccb ccb import medic use cyclosporine-tr organ transplant recipi